Collegium Pharmaceutical Inc. logo

Collegium Pharmaceutical Inc. (COLL)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
23. 19
+0.01
+0.0431%
$
754.64M Market Cap
136.04 P/E Ratio
- Div Yield
558,600 Volume
1.19 Eps
$ 23.18
Previous Close
Add Transaction
Day Range
22.86 23.41
Year Range
21.43 50.79
Want to track COLL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Collegium Pharmaceutical Inc. (COLL) Statistics

Valuation metrics

Market Cap 754.64M
Enterprise value 1.48B
Trailing P/E (ttm) 15.16
Forward P/E 4.58
PEG ratio 0.51
Price/Sales (ttm) 0.93
Price/Book (mrq) 2.41
Enterprise Value/Revenue 1.84
Enterprise Value/EBITDA 3.13

Overview

Shares outstanding 31.71M
Float 32.06M
Shares short 5.94M
% Held by insiders 0.01%
% Held by institutions 1.21%
Average volume (10 days) 701.33K
Average volume (90 days) 777.33K

Price summary

52-Week low 21.43
52-Week high 50.79
Beta 0.76
50-Day moving average 22.75
200-Day moving average 30.84

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin 0.06%
Operating margin 0.2%

Operational effectiveness

Return on assets 0.02%
Return on equity 0.16%

Income Statement

Revenue (ttm) 796.33M
Revenue per share (ttm) 24.9
Quarterly revenue growth (yoy) 0.09%
Gross profit (ttm) 710.08M
EBITDA 415.82M
Net income to common (ttm) 74.95M
Diluted EPS (ttm) 1.48
Quarterly earnings growth (yoy) 5%

Balance Sheet

Total cash (mrq) 421.75M
Total cash per share (mrq) 3.99
Total debt (mrq) 929.69M
Total Debt/Equity (mrq) 2.75
Current ratio (mrq) 1.03%
Book value per share (mrq) 9.61

Cash Flow

Cash flow statement 331.04M
Levered free cash flow (LFCF) 332.62M